PTRH2 promotes the destruction of neurovascular units and glial scar hyperplasia after cerebral ischemia/reperfusion
This study demonstrates that Peptidyl-tRNA hydrolase 2 (PTRH2) is upregulated following cerebral ischemia/reperfusion, where its neuron-specific expression exacerbates early neurovascular unit damage and its astrocyte-specific expression promotes glial scar hyperplasia, likely through the regulation of the AKT signaling pathway.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When blood flow to the brain is suddenly cut off, as happens during a stroke, the damage does not stop when the flow returns. In fact, the moment circulation is restored, a chaotic chemical reaction begins. The returning blood brings a surge of reactive molecules that stress cells, trigger inflammation, and often kill the very neurons the treatment was meant to save. This secondary wave of injury, known as reperfusion injury, is a major reason why many patients suffer permanent disability even after their arteries are cleared. To understand how the brain heals or fails to heal, scientists look at the neurovascular unit. This is not a single organ, but a tightly knit community of cells: neurons that carry signals, tiny blood vessels that supply fuel, and support cells called astrocytes that act as caretakers. When a stroke strikes, this community fractures. Neurons die, blood vessels leak, and the surviving support cells rush to the scene. In the early hours, they try to seal the breach, but in the weeks that follow, they can overgrow, forming a thick, scar-like barrier that blocks new nerve connections from forming. Finding a way to calm this destructive cycle without stopping the necessary repair work is one of the most urgent challenges in modern medicine.
A recent study from researchers in Shanghai and Harbin has identified a specific protein, called PTRH2, that appears to drive much of this damage. The team discovered that this protein behaves differently depending on when it is measured and which cell type it inhabits. In the first few days after a stroke, PTRH2 levels rise sharply inside neurons, the brain's primary signaling cells. As time passes, the protein shifts its focus, becoming most abundant in astrocytes, the support cells that manage the brain's environment. To test what this protein actually does, the researchers used a specialized virus to deliver genetic instructions directly into the brains of rats. They created two scenarios: one where the rats produced too much PTRH2, and another where the protein was silenced. The results were stark. When neurons were forced to make extra PTRH2, the damage was severe. The rats suffered larger areas of dead tissue, more swelling, and a breakdown of the blood-brain barrier, the protective shield that keeps harmful substances out of the brain. The cells died faster, and the delicate connections between blood vessels and nerve cells were torn apart.
The study also looked at the later stages of recovery, focusing on the astrocytes. When the researchers increased PTRH2 levels specifically in these support cells, the outcome was equally negative, but for a different reason. Instead of helping the brain heal, the excess protein triggered the astrocytes to multiply aggressively. They formed a dense, thick scar that physically blocked the regrowth of nerve fibers. This glial scar, while intended to wall off the injury, became a wall that new nerves could not climb over. The researchers found that the protein was also linked to a specific signaling pathway known as AKT, which normally helps cells survive and reduces inflammation. In the damaged brains, high levels of PTRH2 seemed to turn this protective pathway off, leaving cells vulnerable to death and inflammation. Conversely, when the researchers reduced PTRH2 levels, the opposite occurred. The rats showed smaller areas of damage, better preservation of the blood vessel barriers, and less scarring. The support cells remained calm, and the environment became more favorable for nerve repair.
The team traced the mechanism behind these changes, observing that the protein influences the release of inflammatory signals and the production of substances that inhibit nerve growth. In the early phase, the protein's presence in dying neurons seemed to accelerate cell death and weaken the blood vessel walls. In the later phase, its presence in astrocytes drove the formation of the inhibitory scar. The researchers noted that the protein's effect was not uniform; it acted differently depending on the cell type and the stage of recovery. While the study does not yet prove exactly how PTRH2 interacts with the AKT pathway at a molecular level, the evidence strongly suggests that this protein is a key switch that turns protective mechanisms into destructive ones. By showing that removing or reducing PTRH2 can limit the initial injury and prevent the formation of a blocking scar, the work points to a potential new target for therapy. The findings suggest that if doctors could one day control this protein, they might be able to protect the brain's delicate infrastructure during the critical hours after a stroke and clear the path for recovery in the weeks that follow.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.